Literature DB >> 20127398

Etanercept related pseudo-empyema in rheumatoid arthritis.

Doron Rimar1, Michael Rozenbaum, Gleb Slobodin, Nina Boulman, Itzhak Rosner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20127398     DOI： 10.1007/s10067-009-1360-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy.

Authors:  Samuel A Yousem; Sanja Dacic
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

2.  Granulomatous lung disease occurring during etanercept treatment.

Authors:  Kristine Phillips; Michael Weinblatt
Journal:  Arthritis Rheum       Date:  2005-08-15

3.  Sarcoid-like granulomatous disease following etanercept treatment for RA.

Authors:  Alex Kudrin; Edwin R Chilvers; Amel Ginawi; Brian L Hazleman; Meryl H Griffiths; Sathia Thiru; Andrew J K Ostor
Journal:  J Rheumatol       Date:  2007-03       Impact factor: 4.666

Review 4.  Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.

Authors:  Claire Immediato Daïen; Agnes Monnier; Pascal Claudepierre; Arnaud Constantin; Jean-Paul Eschard; Eric Houvenagel; Mahtab Samimi; Stephan Pavy; Edouard Pertuiset; Eric Toussirot; Bernard Combe; Jacques Morel
Journal:  Rheumatology (Oxford)       Date:  2009-05-07       Impact factor: 7.580

5.  Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.

Authors:  P Watson; N Simler; N Screaton; M Lillicrap
Journal:  Rheumatology (Oxford)       Date:  2008-04-02       Impact factor: 7.580

Review 6.  Rheumatoid pleural effusion.

Authors:  Alexandra Balbir-Gurman; Mordechai Yigla; Abraham Menahem Nahir; Yolanda Braun-Moscovici
Journal:  Semin Arthritis Rheum       Date:  2006-06       Impact factor: 5.532

7.  Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report.

Authors:  Alexandra Balbir-Gurman; Ludmila Guralnik; Lael-Anson Best; Eugene Vlodavsky; Mordehai Yigla; Abraham Menahem Nahir; Yolanda Braun-Moscovici
Journal:  J Clin Rheumatol       Date:  2009-02       Impact factor: 3.517

8.  Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.

Authors:  Damien Fouache; Vincent Goëb; Nathalie Massy-Guillemant; Gilles Avenel; Helene Bacquet-Deschryver; Macha Kozyreff-Meurice; Jean-François Ménard; Marc Muraine; Guillaume Savoye; Xavier Le Loët; Christine Tharasse; Olivier Vittecoq
Journal:  Rheumatology (Oxford)       Date:  2009-04-24       Impact factor: 7.580

9.  Etanercept-induced lupus erythematosus presenting as a unilateral pleural effusion.

Authors:  Jafar Abunasser; Faripour A Forouhar; Mark L Metersky
Journal:  Chest       Date:  2008-10       Impact factor: 9.410
  9 in total
  1 in total

1.  Etanercept treatment-related c-ANCA-associated large vessel vasculitis.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Nina Boulman; Michael Rozenbaum; Lisa Kaly; Ofrat Katz Beyar; Doron Rimar
Journal:  Clin Rheumatol       Date:  2015-12-01       Impact factor: 2.980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.